MS4A12
gene geneOn this page
Also known as Ms4a10FLJ20217
Summary
MS4A12 (membrane spanning 4-domains A12, HGNC:13370) is a protein-coding gene on chromosome 11q12.2, encoding Membrane-spanning 4-domains subfamily A member 12 (Q9NXJ0). May be involved in signal transduction as a component of a multimeric receptor complex.
The protein encoded by this gene is a cell surface protein found primarily in the apical membrane of colonocytes. Silencing of this gene in colon cancer cells inhibits the proliferation, cell motility, and chemotactic invasion of cells. This gene is part of a cluster of similar genes found on chromosome 11. Two transcript variants encoding different isoforms have been found for this gene.
Source: NCBI Gene 54860 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 89 total
- MANE Select transcript:
NM_017716
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:13370 |
| Approved symbol | MS4A12 |
| Name | membrane spanning 4-domains A12 |
| Location | 11q12.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Ms4a10, FLJ20217 |
| Ensembl gene | ENSG00000071203 |
| Ensembl biotype | protein_coding |
| OMIM | 606550 |
| Entrez | 54860 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 9 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000016913, ENST00000525951, ENST00000526784, ENST00000530007, ENST00000537076, ENST00000880034, ENST00000880035, ENST00000971815, ENST00000971816, ENST00000971817
RefSeq mRNA: 2 — MANE Select: NM_017716
NM_001164470, NM_017716
CCDS: CCDS53638, CCDS7988
Canonical transcript exons
ENST00000016913 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000720002 | 60501045 | 60501182 |
| ENSE00000720006 | 60501983 | 60502039 |
| ENSE00000720012 | 60503701 | 60503817 |
| ENSE00000720020 | 60506728 | 60506838 |
| ENSE00001107922 | 60507020 | 60507430 |
| ENSE00001107923 | 60497313 | 60497594 |
| ENSE00001107924 | 60492778 | 60492828 |
Expression profiles
Bgee: expression breadth broad, 70 present calls, max score 99.18.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0588 / max 40.4611, expressed in 5 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 114478 | 0.0588 | 5 |
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 99.18 | gold quality |
| rectum | UBERON:0001052 | 99.14 | gold quality |
| colonic mucosa | UBERON:0000317 | 98.86 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 98.53 | gold quality |
| transverse colon | UBERON:0001157 | 89.30 | gold quality |
| ileal mucosa | UBERON:0000331 | 86.59 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 86.57 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.03 | gold quality |
| vermiform appendix | UBERON:0001154 | 77.86 | gold quality |
| large intestine | UBERON:0000059 | 76.43 | gold quality |
| colon | UBERON:0001155 | 75.54 | gold quality |
| caecum | UBERON:0001153 | 72.14 | gold quality |
| colonic epithelium | UBERON:0000397 | 71.49 | gold quality |
| intestine | UBERON:0000160 | 66.34 | gold quality |
| diaphragm | UBERON:0001103 | 63.06 | gold quality |
| tibialis anterior | UBERON:0001385 | 58.31 | silver quality |
| smooth muscle tissue | UBERON:0001135 | 58.22 | gold quality |
| quadriceps femoris | UBERON:0001377 | 55.99 | gold quality |
| vastus lateralis | UBERON:0001379 | 55.86 | gold quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 55.74 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 52.22 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 52.02 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 51.22 | gold quality |
| deltoid | UBERON:0001476 | 51.04 | gold quality |
| right coronary artery | UBERON:0001625 | 50.59 | gold quality |
| thymus | UBERON:0002370 | 49.70 | gold quality |
| myocardium | UBERON:0002349 | 49.68 | gold quality |
| pancreatic ductal cell | CL:0002079 | 49.55 | silver quality |
| epithelial cell of pancreas | CL:0000083 | 49.39 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-125970 | yes | 1264.28 |
| E-ANND-3 | yes | 14.59 |
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): CDX2
miRNA regulators (miRDB)
25 targeting MS4A12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-4778-3P | 99.93 | 70.40 | 1818 |
| HSA-MIR-450B-5P | 99.92 | 71.48 | 3175 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-4517 | 99.76 | 69.19 | 1867 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-7161-5P | 99.68 | 68.92 | 1592 |
| HSA-MIR-548U | 99.65 | 67.78 | 1463 |
| HSA-MIR-4328 | 99.57 | 71.06 | 4094 |
| HSA-MIR-216A-5P | 99.50 | 68.02 | 1288 |
| HSA-MIR-4460 | 99.37 | 68.52 | 615 |
| HSA-MIR-1244 | 99.33 | 68.38 | 832 |
| HSA-MIR-4477B | 99.23 | 70.49 | 1733 |
| HSA-MIR-371A-5P | 99.08 | 66.51 | 1914 |
| HSA-MIR-4477A | 98.83 | 69.75 | 2952 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-6864-5P | 98.38 | 66.59 | 1079 |
| HSA-MIR-7852-3P | 98.37 | 67.98 | 823 |
| HSA-MIR-338-3P | 98.14 | 67.38 | 1137 |
| HSA-MIR-1202 | 97.19 | 66.43 | 827 |
| HSA-MIR-3972 | 97.19 | 66.46 | 808 |
| HSA-MIR-151A-3P | 95.52 | 65.29 | 516 |
| HSA-MIR-4670-5P | 77.22 | 63.41 | 20 |
Literature-anchored findings (GeneRIF, showing 4)
- MS4A12 is a colon-selective store-operated calcium channel promoting malignant cell processes. (PMID:18451174)
- RNA interference of CDX1 and CDX2 and chromatin immunoprecipitation in colon cancer cells revealed that MS4A12 transcript and protein expression is essentially dependent on the presence of endogenous CDX2. (PMID:19781065)
- In early stage colon cancer, the patients with low MS4A12 expression had a poor survival, while in advanced stage colon cancer MS412 had little prognostic value. (PMID:27881006)
- CLCA4 and MS4A12 as the significant gene biomarkers of primary colorectal cancer. (PMID:32797167)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ms4a12 | ENSMUSG00000101031 |
| rattus_norvegicus | Ms4a12 | ENSRNOG00000026387 |
Paralogs (16): MS4A6A (ENSG00000110077), MS4A4A (ENSG00000110079), MS4A3 (ENSG00000149516), MS4A2 (ENSG00000149534), MS4A1 (ENSG00000156738), MS4A6E (ENSG00000166926), MS4A7 (ENSG00000166927), MS4A14 (ENSG00000166928), MS4A5 (ENSG00000166930), MS4A8 (ENSG00000166959), MS4A15 (ENSG00000166961), MS4A10 (ENSG00000172689), TMEM212 (ENSG00000186329), MS4A13 (ENSG00000204979), MS4A18 (ENSG00000214782), MS4A4E (ENSG00000214787)
Protein
Protein identifiers
Membrane-spanning 4-domains subfamily A member 12 — Q9NXJ0 (reviewed: Q9NXJ0)
All UniProt accessions (3): Q9NXJ0, E9PIX5, E9PNI3
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in signal transduction as a component of a multimeric receptor complex.
Subcellular location. Membrane.
Similarity. Belongs to the MS4A family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9NXJ0-1 | 1 | yes |
| Q9NXJ0-2 | 2 |
RefSeq proteins (2): NP_001157942, NP_060186* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007237 | CD20-like_TM | Domain |
| IPR030417 | MS4A | Family |
Pfam: PF04103
UniProt features (16 total): topological domain 5, transmembrane region 4, sequence conflict 3, chain 1, region of interest 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9NXJ0-F1 | 71.30 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 48 (showing top):
SABATES_COLORECTAL_ADENOMA_DN, MARTENS_TRETINOIN_RESPONSE_UP, BRUINS_UVC_RESPONSE_LATE, FEVR_CTNNB1_TARGETS_UP, PRC2_EZH2_UP.V1_DN, MIR616_5P, MIR371B_5P, MIR373_5P, MIR651_3P, MIR450B_5P, MIR4477A, MIR4516, MIR4477B, MIR6780A_5P, MIR4517
GO Biological Process (1): cell surface receptor signaling pathway (GO:0007166)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| signal transduction | 1 |
| binding | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
508 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MS4A12 | MS4A6E | Q96DS6 | 927 |
| MS4A12 | MS4A4E | Q96PG1 | 915 |
| MS4A12 | ZG16 | O60844 | 744 |
| MS4A12 | GUCA2A | Q02747 | 652 |
| MS4A12 | CLCA4 | Q14CN2 | 624 |
| MS4A12 | GUCA2B | Q16661 | 621 |
| MS4A12 | TMIGD1 | Q6UXZ0 | 601 |
| MS4A12 | KRT20 | P35900 | 563 |
| MS4A12 | AQP8 | O94778 | 544 |
| MS4A12 | OOSP4B | A0A2R8Y4Y8 | 507 |
| MS4A12 | REG4 | Q9BYZ8 | 498 |
| MS4A12 | SLC26A3 | P40879 | 488 |
| MS4A12 | TMEM176A | Q96HP8 | 487 |
| MS4A12 | MS4A5 | Q9H3V2 | 478 |
| MS4A12 | TFF3 | Q07654 | 460 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MS4A12 | MALL | psi-mi:“MI:0915”(physical association) | 0.720 |
| PLLP | MS4A12 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MS4A12 | PLLP | psi-mi:“MI:0915”(physical association) | 0.720 |
| MALL | MS4A12 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MS4A12 | FAM3A | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM3A | MS4A12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MS4A12 | STOM | psi-mi:“MI:0914”(association) | 0.350 |
| MALL | MS4A12 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PLLP | MS4A12 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (10): MS4A12 (Two-hybrid), MS4A12 (Two-hybrid), FAM3A (Two-hybrid), PLLP (Two-hybrid), MALL (Two-hybrid), MYADM (Affinity Capture-MS), ATP6V0A1 (Affinity Capture-MS), ATP6V0A2 (Affinity Capture-MS), STOM (Affinity Capture-MS), TMEM63B (Affinity Capture-MS)
ESM2 similar proteins: A0A0A7EPL0, A2RV66, A4QP16, A6QPF4, C4QM85, F4JYG0, O35892, P11836, P13386, P19437, P20490, P41739, P53762, P56645, P70326, P79778, Q01362, Q148B6, Q29131, Q3C1V0, Q3C2E2, Q3SA47, Q3UNB8, Q3V3Q4, Q3YBM2, Q5I2P1, Q5JT82, Q5R8D6, Q5R8E0, Q60HE7, Q68FU0, Q6A058, Q8BVM2, Q8N1N2, Q8NDZ0, Q8QGQ8, Q8WUU8, Q920C4, Q92540, Q96HJ5
Diamond homologs: A6QPF4, P11836, P13386, P19437, P20490, Q01362, Q3C1V0, Q3C2E2, Q3UPL6, Q8N5U1, Q920C4, Q96JA4, Q96JQ5, Q99N05, Q99N07, Q99N09, Q99N10, Q9BY19, Q9H2W1, Q9H3V2, Q9NXJ0, Q96HJ5, Q99N08, Q5REZ6, Q96PG2, Q9GZW8, Q99N03, Q96PG1, Q96DS6, Q2YDM3
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
89 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 80 |
| Likely benign | 6 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
823 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:60503697:T:G | acceptor_gain | 1.0000 |
| 11:60503697:TTAG:T | acceptor_loss | 1.0000 |
| 11:60503700:G:GT | acceptor_loss | 1.0000 |
| 11:60503813:CCGTG:C | donor_gain | 1.0000 |
| 11:60503815:GTG:G | donor_gain | 1.0000 |
| 11:60503816:TG:T | donor_gain | 1.0000 |
| 11:60503817:GG:G | donor_gain | 1.0000 |
| 11:60503818:G:GG | donor_gain | 1.0000 |
| 11:60503819:TAA:T | donor_loss | 1.0000 |
| 11:60506719:T:TA | acceptor_gain | 1.0000 |
| 11:60506726:A:AG | acceptor_gain | 1.0000 |
| 11:60506727:G:GG | acceptor_gain | 1.0000 |
| 11:60492829:G:GG | donor_gain | 0.9900 |
| 11:60501085:G:GT | donor_gain | 0.9900 |
| 11:60501120:G:GT | donor_gain | 0.9900 |
| 11:60503686:T:A | acceptor_gain | 0.9900 |
| 11:60503690:A:AG | acceptor_gain | 0.9900 |
| 11:60503691:T:G | acceptor_gain | 0.9900 |
| 11:60503696:A:AG | acceptor_gain | 0.9900 |
| 11:60503699:A:AG | acceptor_gain | 0.9900 |
| 11:60503700:G:GG | acceptor_gain | 0.9900 |
| 11:60503700:GGT:G | acceptor_gain | 0.9900 |
| 11:60503814:CGTG:C | donor_gain | 0.9900 |
| 11:60503815:GTGG:G | donor_gain | 0.9900 |
| 11:60503816:TGGT:T | donor_gain | 0.9900 |
| 11:60503817:GGTA:G | donor_gain | 0.9900 |
| 11:60506718:AT:A | acceptor_gain | 0.9900 |
| 11:60506719:T:G | acceptor_gain | 0.9900 |
| 11:60506724:TCA:T | acceptor_loss | 0.9900 |
| 11:60506725:CA:C | acceptor_loss | 0.9900 |
AlphaMissense
1744 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 11:60503731:A:C | S168R | 0.987 |
| 11:60503733:T:A | S168R | 0.987 |
| 11:60503733:T:G | S168R | 0.987 |
| 11:60501983:T:C | F139L | 0.986 |
| 11:60501985:T:A | F139L | 0.986 |
| 11:60501985:T:G | F139L | 0.986 |
| 11:60501132:T:C | F122L | 0.985 |
| 11:60501134:T:A | F122L | 0.985 |
| 11:60501134:T:G | F122L | 0.985 |
| 11:60501168:T:A | W134R | 0.972 |
| 11:60501168:T:C | W134R | 0.972 |
| 11:60501064:G:A | G99E | 0.969 |
| 11:60501996:G:A | G143D | 0.968 |
| 11:60503773:G:C | D182H | 0.966 |
| 11:60503710:A:C | S161R | 0.964 |
| 11:60503712:C:A | S161R | 0.964 |
| 11:60503712:C:G | S161R | 0.964 |
| 11:60503752:G:A | G175R | 0.964 |
| 11:60503752:G:C | G175R | 0.964 |
| 11:60501085:G:A | G106E | 0.963 |
| 11:60501084:G:A | G106R | 0.961 |
| 11:60501084:G:C | G106R | 0.961 |
| 11:60501063:G:A | G99R | 0.959 |
| 11:60501063:G:C | G99R | 0.959 |
| 11:60501159:T:G | Y131D | 0.959 |
| 11:60503724:C:A | N165K | 0.958 |
| 11:60503724:C:G | N165K | 0.958 |
| 11:60503753:G:A | G175E | 0.954 |
| 11:60503774:A:C | D182A | 0.953 |
| 11:60501172:G:A | G135D | 0.947 |
dbSNP variants (sampled 300 via entrez): RS1000079688 (11:60492036 G>A,T), RS1000278311 (11:60500402 A>G), RS1000505605 (11:60506498 T>C), RS1000600994 (11:60501683 TA>T,TAA), RS1000811143 (11:60491128 C>T), RS1000885946 (11:60507025 C>G), RS1000913051 (11:60495423 C>T), RS1001097774 (11:60491238 C>A,G,T), RS1001499399 (11:60501607 G>A), RS1001500376 (11:60499911 T>G), RS1001614037 (11:60501813 A>G), RS1001802983 (11:60500755 T>C), RS1001812810 (11:60491064 C>A,T), RS1002015341 (11:60496156 A>G), RS1002057714 (11:60495300 C>T)
Disease associations
OMIM: gene MIM:606550 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004721_17 | Congenital heart disease (maternal effect) | 4.000000e-07 |
| GCST009205_11 | Supramarginal gyrus volume | 9.000000e-06 |
| GCST90002388_537 | Lymphocyte count | 2.000000e-16 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004587 | lymphocyte count |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| (+)-JQ1 compound | decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, increases methylation | 1 |
| Cadmium | increases expression | 1 |
| Rotenone | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.